Reaction
Paroxysmal Nocturnal Haemoglobinuria reporting signals
As of the last recalculation, Paroxysmal Nocturnal Haemoglobinuria appears in 454 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 214.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 163 | 214.0 | 214.6 |
| Ravulizumab | 44 | 165.2 | 165.7 |
| Eltrombopag Olamine | 49 | 109.1 | 109.3 |
| Deferasirox | 29 | 53.5 | 53.6 |
| Cyclosporine | 78 | 38.6 | 38.6 |
| Romiplostim | 10 | 31.1 | 31.1 |